John Jui Jen Lee Decibel Therapeutics, Inc. (DBTX) insider trading activity

DBTX Quotes by TradingView

John Jui Jen Lee is Chief Development Officer of Decibel Therapeutics, Inc.. Currently has a direct ownership of 0 shares of DBTX, which is worth approximately $0. The most recent transaction as insider was on Sep 25, 2023, when has been sold 147,144 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

John Jui-Jen Lee Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 25 2023
SELL
Sale (or disposition) back to the issuer
-
147,144 Reduced 100.0%
0 Common Stock
Jan 26 2023
BUY
Grant, award, or other acquisition
-
120,000 Added 44.92%
147,144 Common Stock
JJL

John Jui Jen Lee

Chief Development Officer
Boston, MA

Track Institutional and Insider Activities on DBTX

Follow Decibel Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DBTX shares.

Notify only if

Insider Trading

Get notified when an Decibel Therapeutics, Inc. insider buys or sells DBTX shares.

Notify only if

News

Receive news related to Decibel Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DBTX